Oxford, AstraZeneca's Nasal COVID Vaccine Failed to Deliver—Going Back to Development Phase?

The nasal take on the COVID-19 vaccine did not bode well in its clinical trials. Oxford and AstraZeneca decided to go on a different route to deliver vaccines to patients, and it is through an intranasal shot to administer the protection without using needles.

Related Keywords

Oxford Astrazeneca ,Isaiah Richard ,Companies Still Develop The Nasal Vaccine ,Pfizer ,Astrazeneca ,University Of Oxford ,Johnson ,Tech Times ,Seeks Emergency Use ,Covid Booster ,Children Aged ,Companies Still Develop ,Ars Technica ,Pfizer Pours ,Detects Covid ,Covid Vaccine ,Covid ,Covid 19 Vaccine ,Nasal Covid 19 Vaccine ,Strazeneca Nasal Covid Vaccine ,Covid 19 Booster Shot ,